Amedeo Smart

Free Medical Literature Service

 

Amedeo

Vaccines
  Free Subscription

07.09.2026

2 BMJ
1 J Gen Virol
1 J Infect
3 J Infect Dis
3 JAMA
1 Lancet
1 MMWR Morb Mortal Wkly Rep
2 N Engl J Med
4 Pediatrics
1 PLoS Comput Biol
1 PLoS Med
4 PLoS One
2 Proc Natl Acad Sci U S A
1 Science
19 Vaccine


    BMJ

  1. YANG YT
    Covid-19 vaccine study: scientific asylum should never have been necessary.
    BMJ. 2026;394:e100738.
    >> Share

  2. O'DOWD A
    UK childhood vaccination rates fall in babies but stabilise at age 5.
    BMJ. 2026;394:e100718.
    >> Share


    J Gen Virol

  3. HAYES JWP, Edwards JC, Valdez KR, Crossley S, et al
    Evaluation of the contribution of the minor envelope complex glycoprotein 3 ectodomain to the porcine reproductive and respiratory syndrome virus 1 neutralizing antibody response.
    J Gen Virol. 2026;107:002328.
    >> Share


    J Infect

  4. WALKER JL, Ribeiro S, Litt D, Patel T, et al
    Antenatal pertussis vaccine effectiveness in England remains high post COVID-19.
    J Infect. 2026;93:106836.
    >> Share


    J Infect Dis

  5. MILLER SL, Billings WZ, John M, Hemme H, et al
    Evaluation of Serum Antibodies as Correlates of Protection Against Norovirus Infection and Disease.
    J Infect Dis. 2026;234:220-228.
    >> Share

  6. BAKER JM, Mijatovic-Rustempasic S, Casey-Moore MC, White B, et al
    Rotavirus-Specific IgA and IgG Patterns During the First 2 Years of Life in the PREVAIL Birth Cohort.
    J Infect Dis. 2026;234:e290-e301.
    >> Share

  7. PINELL-MCNAMARA VA, Ouedraogo HS, Kafando L, Sani O, et al
    Bacterial Meningitis Epidemiology in Burkina Faso and Niger - High-Risk Countries in the Meningitis Belt of Sub-Saharan Africa, 2015-2023.
    J Infect Dis. 2026 Feb 24:jiag116. doi: 10.1093.
    >> Share


    JAMA

  8. LIPSON RA, Senerth E, Watson MA, Saini H, et al
    COVID-19 Vaccine Effectiveness and Safety for the 2026-2027 Respiratory Season.
    JAMA. 2026 Sep 2. doi: 10.1001/jama.2026.18191.
    >> Share

  9. FRYHOFER SA, Garcia AM, Osterholm MT, Walensky RP, et al
    Respiratory Season Virus Vaccines: Restoring Confidence and Trust.
    JAMA. 2026 Sep 2. doi: 10.1001/jama.2026.18338.
    >> Share

  10. SENERTH E, Sheikholeslamian SM, Sivakumaran K, Watson MA, et al
    Influenza Vaccine Effectiveness and Safety for the 2026-2027 Respiratory Season.
    JAMA. 2026 Sep 2. doi: 10.1001/jama.2026.18126.
    >> Share


    Lancet

  11. DA ASCENSAO GONCALVES MA, de Morais AF, Pascoal CA, Montefusco-Pereira CV, et al
    Gold standard vaccine policy as a global health signal.
    Lancet. 2026 Sep 4:S0140-6736(26)01698-3. doi: 10.1016/S0140-6736(26)01698.
    >> Share


    MMWR Morb Mortal Wkly Rep

  12. PINGALI C, Yankey D, Elam-Evans LD, Trahan A, et al
    Vaccination Coverage Among Adolescents Aged 13-17 Years - National Immunization Survey-Teen, United States, 2025.
    MMWR Morb Mortal Wkly Rep. 2026;75:530-538.
    >> Share


    N Engl J Med

  13. WORKMAN S
    Childhood Vaccine Hesitancy.
    N Engl J Med. 2026;395:933.
    >> Share

  14. O'LEARY ST, Danchin M
    Childhood Vaccine Hesitancy. Reply.
    N Engl J Med. 2026;395:934.
    >> Share


    Pediatrics


  15. Recommendations for COVID-19 Vaccines in Infants, Children, and Adolescents, 2026-2027: Technical Report.
    Pediatrics. 2026 Sep 2. doi: 10.1542/peds.2026-079046.
    >> Share


  16. Recommendations for COVID-19 Vaccines in Infants, Children, and Adolescents, 2026-2027: Policy Statement.
    Pediatrics. 2026 Sep 2. doi: 10.1542/peds.2026-079045.
    >> Share

  17. NAURECKAS LI C, Edwards KM, Kaplan SL, Marshall GS, et al
    What's Old Is New Again: Varicella.
    Pediatrics. 2026;158:e2026076519.
    >> Share

  18. PAYNE AB, Battan-Wraith S, Reese SE, Hathaway CA, et al
    Effectiveness of RSV Prevention Strategies in US Infants: 2024-2025.
    Pediatrics. 2026 Aug 4:e2026076089. doi: 10.1542/peds.2026-076089.
    >> Share


    PLoS Comput Biol

  19. FREEDMAN AS, Nielsen BF, Saad-Roy CM, Grenfell BT, et al
    Economic factors promoting vaccine nationalism in the face of viral evolution.
    PLoS Comput Biol. 2026;22:e1014466.
    >> Share


    PLoS Med

  20. ELIAS KM, Mitchell A, Stadler E, Schlub TE, et al
    Neutralising antibodies and protection from progression to severe COVID-19: A meta-analysis.
    PLoS Med. 2026;23:e1005230.
    >> Share


    PLoS One

  21. MALANDE OO, Deogratias M, Songok JJ, Hassan S, et al
    Strengthened HPV vaccination among adolescents living with HIV, - Findings of a Pilot QI project in Kampala Metropolitan, Uganda.
    PLoS One. 2026;21:e0356686.
    >> Share

  22. HAWKES BA, Hollister J, Porter C, Lyski ZL, et al
    Age-specific humoral immune response to SARS-CoV-2: A comparative analysis of antibody levels in children and adults after vaccination with primary series or infection.
    PLoS One. 2026;21:e0356178.
    >> Share

  23. KIM M, Shim E
    Breakthrough infections and incomplete vaccine efficacy drive pathogen immune escape.
    PLoS One. 2026;21:e0356544.
    >> Share

  24. OMIDIMORAD A, Kolahdooz F, Kolahdooz G, Wagg A, et al
    Human papillomavirus (HPV) and HPV vaccine awareness in Indigenous communities in Northwest Territories, Canada.
    PLoS One. 2026;21:e0357586.
    >> Share


    Proc Natl Acad Sci U S A

  25. KARADAKIC R, Keating NL, Barnett ML
    Interpreting vaccine-associated survival differences in immune checkpoint inhibitor therapy.
    Proc Natl Acad Sci U S A. 2026;123:e2621501123.
    >> Share

  26. NISHIDA J, Seehawer M, Rojas Jimenez E, Yan P, et al
    Breast cancer prevention by prophylactic Lalba mRNA-LNP vaccination.
    Proc Natl Acad Sci U S A. 2026;123:e2621855123.
    >> Share


    Science

  27. SEMON A, Manzer HS, Keenan O, Zhou TH, et al
    Early-life colonization with Clostridioides difficile remodels the developing gut.
    Science. 2026;393:1045-1052.
    >> Share


    Vaccine

  28. KORNUTA CA, Zhou G, Kane KP, Vliagoftis H, et al
    Mucosal adjuvant activity of a PAR-2-activating peptide enhances lymph node immune cell recruitment and promotes immune cell activation in a prime-boost influenza vaccination model.
    Vaccine. 2026;92:129110.
    >> Share

  29. ZHENG Y, Qiao B, Gao Z, Zhang X, et al
    Development of a subunit vaccine candidate (RBD-HA trimer) provides dual protection against multi-subtype avian influenza viruses and QX-type infectious bronchitis virus.
    Vaccine. 2026;92:129121.
    >> Share

  30. MARIA DA, Martins IM, Porto GPM, Villas-Boas IM, et al
    Safety, humoral and cellular immune responses to a pre-pandemic adjuvanted influenza A (H5N8) vaccine.
    Vaccine. 2026;92:129049.
    >> Share

  31. TRAN S, McClymont E, Blitz S, Barrett J, et al
    Self-reported reactogenicity after COVID-19 vaccination with and without influenza vaccine coadministration during pregnancy in Canada.
    Vaccine. 2026;92:129122.
    >> Share

  32. ACHARYA KP, Phuyal S, Branda F
    Beyond anthelmintics: Can vaccines offer a sustainable path for liver fluke control?
    Vaccine. 2026;92:129075.
    >> Share

  33. COSTA NS
    Temporal validation of machine-learning models for shingles vaccine nonvaccination among U.S. adults aged 50 years and older.
    Vaccine. 2026;92:129099.
    >> Share

  34. NIAN H, Ding T, Lee RL, Gebretsadik T, et al
    COVID-19 vaccine uptake among individuals with Down syndrome in the Unites States.
    Vaccine. 2026;92:129128.
    >> Share

  35. MOHAMMED H, Andraweera P, Marshall HS
    A cohort study to assess the safety and coverage of COVID-19, influenza, and pertussis vaccine in Australian pregnant women.
    Vaccine. 2026;91:129081.
    >> Share

  36. ALAMI A, Lewis M, El-Chaar D, Walker M, et al
    Maternal vaccination with RSVpreF and risk of hypertensive disorders of pregnancy: a systematic review and meta-analysis.
    Vaccine. 2026;91:129070.
    >> Share

  37. MCCONEGHY KW, Wilker EH, DeVone F, Skov B, et al
    Erratum to "Vaccine effectiveness of mRNA-1345 against RSV-associated hospitalization and medically attended acute respiratory illness among US veterans, 2025-2026" [Vaccine 88 (2026) 128882].
    Vaccine. 2026 Aug 29:129072. doi: 10.1016/j.vaccine.2026.129072.
    >> Share

  38. SIMUZINGILI M, Fernandez-Soberon S, Yi Z, Cossrow N, et al
    Evaluating the potential lifetime health and economic impact of PCV21, an adult-specific 21-valent pneumococcal conjugate vaccine, on invasive pneumococcal disease in adults aged >/=45 years in Spain.
    Vaccine. 2026;91:129077.
    >> Share

  39. MUSRATI MA, Shenaisheh S, Elemraid MA
    Ethical considerations of incentive structures in vaccine acceptance research.
    Vaccine. 2026;91:129102.
    >> Share

  40. TAN L, Fang Y, Liu P, Su M, et al
    An immunoinformatics-based multi-epitope vaccine candidate confers cross-protection against two Actinobacillus pleuropneumoniae serovars.
    Vaccine. 2026;91:129104.
    >> Share

  41. GAO SL, Yan JC, Wang J, Liu QY, et al
    A recombinant attenuated PRRSV vaccine expressing the PCV2 capsid protein confers protective immunity in pigs.
    Vaccine. 2026;91:129106.
    >> Share

  42. ANDREWS JR, Hermans S, White RG, Garcia-Basteiro AL, et al
    Evaluating the influence of vaccine archetypes and epidemiological conditions on clinical trial metrics for tuberculosis vaccine candidates.
    Vaccine. 2026;91:129097.
    >> Share

  43. ZHANG J, Askenase P, Crumpacker C
    A leap forward in vaccination - a molecular process of epigenetic silencing to the virus.
    Vaccine. 2026;91:129119.
    >> Share

  44. IONESCU IG, Ouakki M, Breton O, Panicker G, et al
    Follow up immunogenicity of a mixed vaccination schedule with one dose of nonavalent and one dose of bivalent HPV vaccines 36 months post-vaccination among boys and girls.
    Vaccine. 2026;92:129107.
    >> Share

  45. SHEN AK, Tupps C, Bino S, Chipoya M, et al
    Investments in seasonal influenza vaccination programs pack a punch for pandemic preparedness.
    Vaccine. 2026;92:129098.
    >> Share

  46. DUDLEY MZ, Ali H, Villaescusa MR, Law B, et al
    Incidence, risk factors, and association with vaccination of thrombocytopenia and immune thrombocytopenia (ITP): A scoping review.
    Vaccine. 2026;92:129120.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016